SCHEMBL30561968

SCHEMBL30561968

COCCN(CCOC)C(=O)c1cccc2c3c([nH]c12)CN(C(=O)Cc1ccccc1F)CC3

nearest known ligand 0.45

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 8/20 0.45
▸ CCND1 P24385 8/20 0.45
▸ HDAC6 Q9UBN7 3/20 0.42
▸ GPX4 P36969 1/20 0.41
▸ TRPV1 Q8NER1 6/20 0.40
▸ HDAC1 Q13547 2/20 0.37
▸ PARP1 P09874 1/20 0.37
▸ FAAH O00519 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30561929 0.90 CDK4 (0.48) CDK4CCND1HDAC6GPX4TRPV1
SCHEMBL30561941 0.85 CDK4 (0.48) CDK4CCND1HDAC6GPX4TRPV1
SCHEMBL30561940 0.83 CDK4 (0.51) CDK4CCND1HDAC6GPX4TRPV1
SCHEMBL30561933 0.79 CDK4 (0.52) CDK4CCND1HDAC6GPX4TRPV1
SCHEMBL30561951 0.79 CDK4 (0.51) CDK4CCND1HDAC6GPX4TRPV1
SCHEMBL30561935 0.77 GPX4 (0.67) CDK4CCND1HDAC6GPX4TRPV1
SCHEMBL30562002 0.69 CDK4 (0.61) CDK4CCND1TRPV1FAAH
SCHEMBL30562026 0.68 GPX4 (0.65) CDK4CCND1HDAC6GPX4TRPV1
SCHEMBL21588274 0.65 TRPV1 (0.48) CDK4CCND1TRPV1PARP1FAAH
SCHEMBL13942347 0.64 CDK4 (0.83) CDK4CCND1GPX4TRPV1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116836160-A Fluoro-phenylacetyl tetrahydro-beta-carboline micromolecule organic compound for targeting tumor dryness and medical application thereof 华东师范大学 2023-10-03 — — CN claimed
CN-116836160-A Fluoro-phenylacetyl tetrahydro-beta-carboline micromolecule organic compound for targeting tumor dryness and medical application thereof 华东师范大学 2023-10-03 — — CN disclosed
Send feedback